Picard Medical Statistics
Total Valuation
Picard Medical has a market cap or net worth of $10.78 million. The enterprise value is $12.32 million.
| Market Cap | 10.78M |
| Enterprise Value | 12.32M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026, before market open.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Picard Medical has 2.34 million shares outstanding. The number of shares has increased by 802.75% in one year.
| Current Share Class | 2.34M |
| Shares Outstanding | 2.34M |
| Shares Change (YoY) | +802.75% |
| Shares Change (QoQ) | +24.66% |
| Owned by Insiders (%) | 4.52% |
| Owned by Institutions (%) | 9.97% |
| Float | 1.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.71 |
| Forward PS | 1.86 |
| PB Ratio | 5.52 |
| P/TBV Ratio | 16.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.92.
| Current Ratio | 1.02 |
| Quick Ratio | 0.09 |
| Debt / Equity | 0.92 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.24 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -93.62% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -910.84% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $84,000 |
| Profits Per Employee | -$352,227 |
| Employee Count | 75 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 0.79 |
Taxes
In the past 12 months, Picard Medical has paid $11,000 in taxes.
| Income Tax | 11,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.94% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -98.94% |
| 50-Day Moving Average | 5.35 |
| 200-Day Moving Average | 43.11 |
| Relative Strength Index (RSI) | 45.15 |
| Average Volume (20 Days) | 431,100 |
Short Selling Information
The latest short interest is 231,853, so 9.91% of the outstanding shares have been sold short.
| Short Interest | 231,853 |
| Short Previous Month | 76,345 |
| Short % of Shares Out | 9.91% |
| Short % of Float | 18.09% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, Picard Medical had revenue of $6.30 million and -$26.42 million in losses. Loss per share was -$17.88.
| Revenue | 6.30M |
| Gross Profit | 1.17M |
| Operating Income | -15.63M |
| Pretax Income | -27.98M |
| Net Income | -26.42M |
| EBITDA | -15.46M |
| EBIT | -15.63M |
| Loss Per Share | -$17.88 |
Balance Sheet
The company has $38,000 in cash and $1.58 million in debt, with a net cash position of -$1.54 million or -$0.66 per share.
| Cash & Cash Equivalents | 38,000 |
| Total Debt | 1.58M |
| Net Cash | -1.54M |
| Net Cash Per Share | -$0.66 |
| Equity (Book Value) | 1.72M |
| Book Value Per Share | 0.83 |
| Working Capital | 141,000 |
Cash Flow
In the last 12 months, operating cash flow was -$16.04 million and capital expenditures -$26,000, giving a free cash flow of -$16.07 million.
| Operating Cash Flow | -16.04M |
| Capital Expenditures | -26,000 |
| Depreciation & Amortization | 172,000 |
| Net Borrowing | -1.90M |
| Free Cash Flow | -16.07M |
| FCF Per Share | -$6.87 |
Margins
| Gross Margin | 18.60% |
| Operating Margin | -248.10% |
| Pretax Margin | -444.16% |
| Profit Margin | n/a |
| EBITDA Margin | -245.37% |
| EBIT Margin | -248.10% |
| FCF Margin | n/a |
Dividends & Yields
Picard Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -802.75% |
| Shareholder Yield | -802.75% |
| Earnings Yield | -245.03% |
| FCF Yield | -149.05% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 3, 2026. It was a reverse split with a ratio of 1:50.
| Last Split Date | Aug 3, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
Picard Medical has an Altman Z-Score of -2.44 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.44 |
| Piotroski F-Score | 4 |